N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro

Journal of Nutritional Biochemistry

Volumn 24, Issue 5, 2013, Pages 744-753

  Yang, Ting ^a   Fang, Shi ^a   Zhang, Hai Xia ^a   Xu, Li Xiao ^a   Zhang, Zhan Qiang ^a   Yuan, Kai Tao ^a   Xue, Cong Long ^a   Yu, Hong Lan ^a   Zhang, Sheng ^b   Li, Yu Fei ^b   Shi, Han Ping ^a   Zhang, Yan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer stem like cells; Colorectal cancer; DHA; EPA; N 3 PUFAs

Indexed keywords

BMI1 PROTEIN; DOCOSAHEXAENOIC ACID; FLUOROURACIL; ICOSAPENTAENOIC ACID; LIPOCORTIN 5; MITOMYCIN; OCTAMER TRANSCRIPTION FACTOR 4; POLYUNSATURATED FATTY ACID; TRANSCRIPTION FACTOR SOX2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL VIABILITY; COLORECTAL CANCER; IN VITRO STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DNA FRAGMENTATION; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FLUOROURACIL; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, NUDE; MITOMYCIN; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR;

MUS MUSCULUS;

EID: 84876783454     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.03.023     Document Type: Article

References (39)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Ricci-Vitiani L., Fabrizi E., Palio E., De Maria R. Colon cancer stem cells. J Mol Med 2009, 87:1097-1104.
3. Moyad M.A. An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II. Urol Oncol 2005, 23:36-48.
4. Su H.M., Hsieh P.H., Chen H.F. A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring. J Nutr Biochem 2010, 21:1033-1037.
5. Patterson R.E., Flatt S.W., Newman V.A., Natarajan L., Rock C.L., Thomson C.A., et al. Marine fatty acid intake is associated with breast cancer prognosis. J Nutr 2011, 141:201-206.
6. Tavani A., Pelucchi C., Parpinel M., Negri E., Franceschi S., Levi F., et al. n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland. Int J Cancer 2003, 105:113-116.
7. McEntee M.F., Ziegler C., Reel D., Tomer K., Shoieb A., Ray M., et al. Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer. Am J Pathol 2008, 173:229-241.
8. Kato T., Kolenic N., Pardini R.S. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 2007, 58:178-187.
9. MacLean C.H., Newberry S.J., Mojica W.A., Khanna P., Issa A.M., Suttorp M.J., et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006, 295:403-415.
10. Berquin I.M., Edwards I.J., Chen Y.Q. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 2008, 269:363-377.
11. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Annu Rev Med 2007, 58:267-284.
12. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
13. Trumpp A., Wiestler O.D. Mechanisms of disease: cancer stem cells-targeting the evil twin. Nat Clin Pract Oncol 2008, 5:337-347.
14. Dontu G., Liu S., Wicha M.S. Stem cells in mammary development and carcinogenesis: implications for prevention and treatment. Stem Cell Rev 2005, 1:207-213.
15. Gespach C. Stem cells and colon cancer: the questionable cancer stem cell hypothesis. Gastroenterol Clin Biol 2010, 34:653-661.
16. Alison M.R., Islam S. Attributes of adult stem cells. J Pathol 2009, 217:144-160.
17. Todaro M., Francipane M.G., Medema J.P., Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010, 138:2151-2162.
18. Di Stefano A.B., Iovino F., Lombardo Y., Eterno V., Höger T., Dieli F., et al. Survivin is regulated by interleukin-4 in colon cancer stem cells. J Cell Physiol 2010, 225(2):555-561.
19. Cammareri P., Scopelliti A., Todaro M., Eterno V., Francescangeli F., Moyer M.P., et al. Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. Cancer Res 2010, 70:4655-4665.
20. Jakobsen C.H., Størvold G.L., Bremseth H., Follestad T., Sand K., Mack M., et al. DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis. J Lipid Res 2008, 49:2089-2100.
21. Papailiou J., Bramis K.J., Gazouli M., Theodoropoulos G. Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis 2011, 26:1-11.
22. Boman B.M., Wicha M.S. Cancer stem cells: a step toward the cure. J Clin Oncol 2008, 26:2795-2799.
23. Donnenberg V.S., Landreneau R.J., Donnenberg A.D. Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. J Control Release 2007, 122:385-391.
24. Morita Y., Iseki A., Okamura S., Suzuki S., Nakauchi H., Ema H. Functional characterization of hematopoietic stem cells in the spleen. Exp Hematol 2011, 39:351-359.
25. McDermott S.P., Wicha M.S. Targeting breast cancer stem cells. Mol Oncol 2010, 4:404-419.
26. Notarnicola M., Messa C., Refolo M.G., Tutino V., Miccolis A., Caruso M.G. Polyunsaturated fatty acids reduce fatty acid synthase and hydroxy-methyl-glutaryl CoA-reductase gene expression and promote apoptosis in HepG2 cell line. Lipids Health Dis 2011, 10:10.
27. Murff H.J., Shu X.O., Li H., Yang G., Wu X., Cai H., et al. Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. Int J Cancer. Int J Cancer. 2011, 128:1434-1441.
28. Vissapragada S., Ghosh A., Ringer L., Salinas P., Brophy A., Peaceman D., et al. Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model. Cell Cycle 2010, 9:1824-1829.
29. Sasazuki S., Inoue M., Iwasaki M., Sawada N., Shimazu T., Yamaji T., et al. Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan public health center-based prospective study. Int J Cancer 2011, 129(7):1718-1729.
30. Llor X., Pons E., Roca A., Alvarez M., Mane J., Fernandez-Banares F., et al. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin Nutr 2003, 22:71-79.
31. IF, Hasio A.C., u M.C., Yang F.M., Su H.M. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells. J Nutr Biochem 2010, 21:512-517.
32. Davidson L.A., Nguyen D.V., Hokanson R.M., Callaway E.S., Isett R.B., Turner N.D., et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 2004, 64:6797-6804.
33. Gupta R.A., Sarraf P., Brockman J.A., Shappell S.B., Raftery L.A., Willson T.M., et al. Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. J Biol Chem 2003, 278:7431-7438.
34. Fan Y.Y., Spencer T.E., Wang N., Moyer M.P., Chapkin R.S. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 2003, 24:1541-1548.
35. Hardman W.E., Avula C.P., Fernandes G., Cameron I.L. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 2001, 7:2041-2049.
36. Xue H., Sawyer M.B., Field C.J., Dieleman L.A., Baracos V.E. Nutritional modulation of antitumor efficacy and diarrhea toxicity related to irinotecan chemotherapy in rats bearing the ward colon tumor. Clin Cancer Res 2007, 13:7146-7154.
37. Colas S., Mahéo K., Denis F., Goupille C., Hoinard C., Champeroux P., et al. Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. Clin Cancer Res 2006, 12:5879-5886.
38. GómezdeSegura I.A., Valderrábano S., Vázquez I., Vallejo-Cremades M.T., Gómez-García L., Sánchez M., et al. Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracilinduced intestinal injury in the rat. Eur J Gastroenterol Hepatol 2004, 16:479-485.
39. Cha M.C., Meckling K.A., Stewart C. Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice. Nutr Cancer 2002, 44:176-181.